Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CBA Florida, Inc.CBAI · Entity 148644 | Co-Chief Executive Officer · 10% owner | June 04, 2020 | June 08, 2020 |
| CRYO CELL INTERNATIONAL INCCCEL · Entity 7400 | Director · Chairman, Co-CEO · 10% owner | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CBA Florida, Inc.
Report date June 04, 2020 · Filed June 08, 2020
Jointly reported with CRYO CELL INTERNATIONAL INC, Portnoy Mark L.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,663,572 |
Reported balance
After 2020-06-04 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2020-06-04 · Sale · Disposed 530,000 · Balance 4,663,572 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 3,433,483 |
Reported balance
After 2020-06-05 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2020-06-05 · Sale · Disposed 1,230,089 · Balance 3,433,483 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 114,207,446 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 114,207,446 F1: Shares owned solely by Cryo-Cell International, Inc. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 5,614,932 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,614,932 F2: Shares owned solely by David I. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 4,061,770 |
Reported balance
Holding disclosure · report date 2020-06-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,061,770 F3: Shares owned solely by Mark L. Portnoy. F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares owned solely by Cryo-Cell International, Inc.
F2: Shares owned solely by David I. Portnoy.
F3: Shares owned solely by Mark L. Portnoy.
F4: Messrs. Portnoy and Portnoy, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
CRYO CELL INTERNATIONAL INC
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 247,438 |
Reported balance
After 2026-08-05 transaction · row 1
1 source rowRow 1 · 2026-08-05 · Other · Disposed 600,191 · Balance 247,438 F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy David Portnoy Irrevocable 2026 Trust Agreement | 600,191 |
Reported balance
After 2026-08-05 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-05 · Other · Acquired 600,191 · Balance 600,191 F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Corporation | 161,833 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 161,833 F2: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. |
| Common StockSEC Table I · non-derivative | IndirectBy Corporation | 57,306 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 57,306 F3: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary. |
| Common StockSEC Table I · non-derivative | IndirectBy 401K | 164,182 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 164,182 |
| Common StockSEC Table I · non-derivative | IndirectBy IRA | 268,878 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 268,878 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 107,403 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 107,403 |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 59,027 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 59,027 F4: Shares of common stock held by Mayim Limited Partnership, as to which David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership. |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 12,214 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 12,214 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 11,804 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 10
Holding and transaction disclosures are not merged.
1 source rowRow 10 · Balance 11,804 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian for son | 11,212 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 11
Holding and transaction disclosures are not merged.
1 source rowRow 11 · Balance 11,212 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.53 · Expires 2029-08-30 | Direct | 26,243 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 26,243 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.28 · Expires 2029-12-20 | Direct | 23,636 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 23,636 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.27 · Expires 2028-12-22 | Direct | 280,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 280,000 F5: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.77 · Expires 2028-01-03 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 50,000 F6: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $4.30 · Expires 2027-12-23 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 50,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.47 · Expires 2028-12-22 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 50,000 F7: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.08 · Expires 2030-01-21 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 50,000 F8: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 50,000 F9: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.89 · Expires 2031-01-07 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2026-08-05 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 150,000 F10: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein.
F2: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
F3: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
F4: Shares of common stock held by Mayim Limited Partnership, as to which David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
F5: Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
F6: 8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
F7: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
F8: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
F9: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028.
F10: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 05, 2026 Filed Aug 7, 2026 20:39 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherCommon Stock | 600,191 | $1.33 | $799,994.58 |
DisclosureSEC source: 0001193125-26-340392 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By David Portnoy Irrevocable 2026 Trust Agreement Disclosed balance after: 600,191 F1 · kind: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:39 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherCommon Stock | 600,191 | $1.33 | $799,994.58 |
DisclosureSEC source: 0001193125-26-340392 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,438 F1 · kind: On August 5, 2026, the Reporting Person transferred 600,191 shares of the Issuer's common stock to the David Portnoy Irrevocable 2026 Trust Agreement (the "Trust"). In connection with the transfer, the Trust borrowed $800,000.26, the proceeds of which were used to satisfy outstanding indebtedness of the Reporting Person. The Reporting Person personally guaranteed the Trust's repayment obligations. The price reported in Column 4 represents $800,000.26 divided by the 600,191 shares transferred and does not represent the fair market value of the shares. Deborah Portnoy, the Reporting Person's spouse, is the sole trustee. The Reporting Person is not a beneficiary of the Trust, has no power to revoke the Trust and, for purposes of Section 16 reporting, disclaims beneficial ownership of the shares held by the Trust except to the extent of any pecuniary interest therein. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 150,000 | $3.89 Strike: $3.89 | $583,500.00 |
DisclosureSEC source: 0001193125-26-009073 · ownership.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2031-01-07 F9 · derivative.exercise_date: The stock options were granted pursuant to the Cryo-Cell 2022 Stock Incentive Plan and an individual award agreement. The options are divided into three equal tranches, each subject to both time-based vesting and stock-price performance conditions. One tranche vests after the first anniversary of the grant date and upon the Company's common stock achieving an average closing price of at least $6 per share over 20 consecutive trading days. One tranche vests after the second anniversary and upon achieving an average closing price of at least $8 per share over 20 consecutive trading days. One tranche vests after the third anniversary and upon achieving an average closing price of at least $10 per share over 20 consecutive trading days, in each case subject to the reporting person's continued service to the Company. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $3.89 Strike: $3.89 | $194,500.00 |
DisclosureSEC source: 0001193125-26-009073 · ownership.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-01-07 F8 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 7, 2027 and 1/3 on January 7, 2028. Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 273 | $4.10 | $1,119.30 |
DisclosureSEC source: 0001193125-25-293823 · ownership.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 11,212 Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 406 | $4.09 | $1,660.54 |
DisclosureSEC source: 0001193125-25-293823 · ownership.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 11,804 Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 677 | $4.09 | $2,768.93 |
DisclosureSEC source: 0001193125-25-293823 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 12,214 Read SEC document |
| November 21, 2025 Filed Nov 24, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 800 | $4.04 | $3,232.00 |
DisclosureSEC source: 0001193125-25-293823 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 847,629 Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 289 | $4.00 | $1,156.00 |
DisclosureSEC source: 0001193125-25-293823 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 846,829 Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 22:11 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 1,921 | $4.08 | $7,837.68 |
DisclosureSEC source: 0001193125-25-288306 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 846,540 F1 · price: The price reported is a weighted average price of $4.08. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 22:11 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 640 | $4.09 | $2,617.60 |
DisclosureSEC source: 0001193125-25-288306 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 844,619 Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 22:11 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 1,429 | $4.00 | $5,716.00 |
DisclosureSEC source: 0001193125-25-288306 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,979 Read SEC document |
| November 12, 2025 Filed Nov 12, 2025 22:01 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 2,040 | $4.12 | $8,404.80 |
DisclosureSEC source: 0001193125-25-277890 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 842,550 F2 · price: The price reported is a weighted average price of $4.12. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2025 Filed Nov 12, 2025 22:01 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 2,474 | $4.13 | $10,217.62 |
DisclosureSEC source: 0001193125-25-277890 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 840,510 F1 · price: The price reported is a weighted average price of $4.13. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 22:01 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 1,026 | $4.18 | $4,288.68 |
DisclosureSEC source: 0001193125-25-277890 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838,036 Read SEC document |
| November 04, 2025 Filed Nov 4, 2025 22:26 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 5,000 | $4.40 | $22,000.00 |
DisclosureSEC source: 0001193125-25-265046 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 837,010 F1 · price: The price reported is a weighted average price of $4.40. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 22:26 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantCommon Stock | 4,666 | $4.45 | $20,763.70 |
DisclosureSEC source: 0001193125-25-265046 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 832,010 Read SEC document |
| September 18, 2025 Filed Sep 18, 2025 20:53 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 1,751 | $4.49 | $7,861.99 |
DisclosureSEC source: 0001193125-25-207528 · ownership.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Corporation Disclosed balance after: 161,833 F4 · ownership.nature: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. Read SEC document |
| September 18, 2025 Filed Sep 18, 2025 20:53 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 3,411 | $4.46 | $15,213.06 |
DisclosureSEC source: 0001193125-25-207528 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 827,344 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2025 Filed Sep 18, 2025 20:53 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 5,564 | $4.43 | $24,648.52 |
DisclosureSEC source: 0001193125-25-207528 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 823,933 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.41 to $4.45, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 20:53 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 6,449 | $4.46 | $28,762.54 |
DisclosureSEC source: 0001193125-25-207528 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 818,369 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.40 to $4.47, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 2,087 | $4.48 | $9,349.76 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 10 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Corporation Disclosed balance after: 57,306 F5 · ownership.nature: Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary. Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 7,200 | $4.48 | $32,256.00 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 9 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Corporation Disclosed balance after: 160,082 F4 · ownership.nature: Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary. Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 7,178 | $4.42 | $31,726.76 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 8 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 811,920 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.45, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 4,817 | $4.47 | $21,531.99 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 7 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 107,403 Read SEC document |
| September 10, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 11,035 | $4.40 | $48,554.00 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 6 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 268,878 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.45, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 156 | $4.49 | $700.44 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 10,939 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 156 | $4.48 | $698.88 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 11,398 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 185 | $4.49 | $830.65 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for son Disclosed balance after: 11,537 Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 4,815 | $4.49 | $21,619.35 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 257,843 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.48 to $4.49, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:22 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 5,271 | $4.31 | $22,718.01 |
DisclosureSEC source: 0000950170-25-114029 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 253,028 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.30 to $4.32, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 21:18 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | OtherCommon Stock | 15,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-112560 · ownership.xml · nonDerivative · entry 12 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · As Custodian for Daughter Disclosed balance after: 0 F4 · acquired: Child reached age of majority and reporting person no longer has beneficial ownership. Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 6,218 | $4.44 | $27,607.92 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 6 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 247,757 Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 7,860 | $4.42 | $34,741.20 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 164,182 F9 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.41 to $4.44, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 26, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 11,101 | $4.44 | $49,288.44 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 156,322 F8 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.36 to $4.46, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 4,500 | $4.53 | $20,385.00 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 241,539 F7 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.48 to $4.55, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 5,000 | $4.65 | $23,250.00 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 145,221 Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 21:23 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 4,500 | $4.65 | $20,925.00 |
DisclosureSEC source: 0000950170-25-111745 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 140,221 Read SEC document |
| August 19, 2025 Filed Aug 19, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 885 | $4.37 | $3,867.45 |
DisclosureSEC source: 0000950170-25-110173 · ownership.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 135,721 Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 9,327 | $4.37 | $40,758.99 |
DisclosureSEC source: 0000950170-25-110173 · ownership.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 134,836 F9 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.23 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 6,418 | $4.43 | $28,431.74 |
DisclosureSEC source: 0000950170-25-110173 · ownership.xml · nonDerivative · entry 2 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By IRA Disclosed balance after: 237,039 F8 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.34 to $4.50, inclusive. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2025 Filed Aug 19, 2025 21:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 2,671 | $4.50 | $12,019.50 |
DisclosureSEC source: 0000950170-25-110173 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 125,509 F7 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at $4.50. Read SEC document |
| August 14, 2025 Filed Aug 18, 2025 21:34 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 5,826 | $4.17 | $24,305.49 |
DisclosureSEC source: 0000950170-25-109852 · ownership.xml · nonDerivative · entry 1 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By 401K Disclosed balance after: 122,838 Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $8.08 Strike: $8.08 | $404,000.00 |
DisclosureSEC source: 0000950170-25-008394 · ownership.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-21 F6 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027. Read SEC document |
| December 22, 2023 Filed Dec 28, 2023 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $6.47 Strike: $6.47 | $323,500.00 |
DisclosureSEC source: 0001209191-23-059918 · doc4.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-12-22 F7 · derivative.exercise_date: Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 22:27 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $4.77 Strike: $4.77 | $238,500.00 |
DisclosureSEC source: 0001209191-23-001973 · doc4.xml · derivative · entry 18 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-01-03 F5 · derivative.exercise_date: 8,750 options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026. Read SEC document |
| December 23, 2022 Filed Jan 6, 2023 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | GrantStock Option · Derivative | 50,000 | $4.30 Strike: $4.30 | $215,000.00 |
DisclosureSEC source: 0001209191-23-002380 · doc4.xml · derivative · entry 19 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-12-23 F6 · derivative.exercise_date: Pursuant to the executive's Employment Agreement effective December 1, 2022, stock options will be awarded and will vest immediately if the price of the Company's stock reaches $8.00 per share during the five-year option term. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 2 | $4.86 | $9.72 |
DisclosureSEC source: 0001209191-22-058194 · doc4.xml · nonDerivative · entry 5 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 230,621 Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 532 | $4.90 | $2,606.80 |
DisclosureSEC source: 0001209191-22-058194 · doc4.xml · nonDerivative · entry 4 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 230,619 Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 22:00 UTC | CRYO CELL INTERNATIONAL INC CCEL · Entity 7400 | PurchaseCommon Stock | 516 | $4.90 | $2,528.40 |
DisclosureSEC source: 0001209191-22-058194 · doc4.xml · nonDerivative · entry 3 PORTNOY DAVID · CIK 0001315416 · Director · Chairman, Co-CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 230,087 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.